ppt case rscm1

Upload: juliyanti-fu

Post on 14-Apr-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/29/2019 Ppt Case Rscm1

    1/21

    Diagnostic Value of Adenosine Deaminase (ADA)

    in Ascitic Fluid for Peritoneal Tuberculosis:

    an Evidence-based Case Report

    Author : dr. Juliyanti

    Chief of Ward: dr. Mulia

    Supervisor: dr. Nadia Ayu Mulansari, SpPD

  • 7/29/2019 Ppt Case Rscm1

    2/21

    Introduction

    Tuberculosis causes some 2 million deaths per year world wideand is increasing in incidence in developed and developingcountries.

    The peritoneum is the sixth most common extra pulmonary site.

    The reported incidence of peritoneal TB among all forms of TBvaries from 0.1% to 0.7% worldwideand it can be expected to

    increase with the increasing incidence of TB worldwide.

  • 7/29/2019 Ppt Case Rscm1

    3/21

    Peritoneal tuberculosis

    Usually results from the reactivation of latent TB in peritoneal focithat were established after hematogenous spread from a primarylung focus.

    Manifested as ascites of insidious onset, abdominal pain and fever.

    The non-specific symptoms associated with PTB and its challengingclinical course can interfere with a definitive diagnosis, and TBperitonitis is often confused with other intra-abdominal diseases.

    Delayed diagnosis increases the morbidity and mortality of PTB.

  • 7/29/2019 Ppt Case Rscm1

    4/21

    Diagnosis of PTB

    Diagnostic tests for PTB are difficult and time-consuming because

    of paucity of M. tuberculosis in peritoneal fluid.

    It requires histological confirmation of caseous granulomas or

    bacteriological confirmation, by using ascitic fluid-derived acid-

    fast bacilli (AFB) smears as well as cultures for M. tuberculosis.

    Cultures for M. tuberculosis require 4 weeks and AFB smears aretoo insensitive to meet current needs.

    A laparoscopy-guided biopsy can be used to obtain a rapid

    diagnosis of PTB; however it is associated with risks related toanesthesia and potential injury and bleeding.

  • 7/29/2019 Ppt Case Rscm1

    5/21

    Adenosine deaminase (ADA)

    ADA is a purine-degrading enzyme that catalyses thedeamination of adenosine, resulting in the production of inosine

    ADA is widely distributed in tissues and body fluids, and its levelscan be used to differentiate T cells from B cells; ADA levels are

    1012 times higher in T cells than in B cells; its level vary with theproliferative status and the maturity of cells.

    ADA is increased in tuberculous ascitic fluid because of thestimulation of T cells by the mycobacterial antigens. Its levels in

    body fluids can be measured rapidly, provide an alternative forthe diagnosis of TB.

  • 7/29/2019 Ppt Case Rscm1

    6/21

    Case resume

    Female, 51 years old, with chief complaint of progressiveabdominal swelling since 2 months prior to admission.

    She had abdominal pain occasionally, malaise, anorexia andweight loss but had no history of night sweat or fever.

    She had no history of prior liver disease or alcoholic abuse,denied symptoms of dyspnea, cough, chest pain or legswelling

    She was diagnosed with diabetes mellitus and hypertensionsince 3 years before and was regularly on lisinopril and

    metformin. She was non-smoker, menopause 6 years ago and had no

    complaint of vaginal bleeding.

  • 7/29/2019 Ppt Case Rscm1

    7/21

    Case resume (2)

    Physical examination revealed normal vital sign, dullness

    on percussion of left lower thorax with decreased breath

    sound, positive shifting dullness on abdomen, no

    stigmata of hepatic cirrhosis and no peripheral edema.

    Laboratory result showed leukocytosis, thrombocytosis,

    elevated ESR, moderate hyponatremia, hyperglycemia,

    normal kidney and liver function test, elevated CA 125

    level (537 U/mL), normal albumin and increased globulin.

    Serological test for HIV, hepatitis B and C were negative.Fecal and urine analysis were normal

  • 7/29/2019 Ppt Case Rscm1

    8/21

    Case resume (3)

    Chest x-ray revealed left sided pleural effusion with nosign of parenchymal involvement. Abdominal ultrasoundsshowed free peritoneal fluid with no significant finding inabdominal viscera. An abdominal CT scan showedabundant free fluid but no other sign of abnormality.

    Gynecological study revealed normal result exceptadhesive fibrin on ascitic fluid.

    A diagnostic paracentesis was carried out, and a clearyellowish ascitic fluid was obtained that contained 1650cells/ul, 99.9 % of which were mononuclear cells

    (lymphocyte). LDH was very high, proteins wereincreased, serum-asites albumin gradient was < 1,1 g/dl(0,5 g/dl) and A Ziehl-Neelsen stain was negative. AsciticADA level was high (107,1 U/L).

  • 7/29/2019 Ppt Case Rscm1

    9/21

    Formulate clinical question

    In practice, we are facing with diagnostic problem of thispatient with exudative asites and lymphocyte predominantpleiocytosis her ascitic fluid that suggestive a peritonealtuberculosis but ascitic fluid revealed negative for AFB

    Gold standard for diagnosis of PTB either time consuming orinvasive, so we tried to find other rapid diagnostic tool

    We were informed that ADA level can be used to determinewhether her ascites was due to TB infection or not, but we stilldid not know about the accuracy of this assay

    Therefore, we formulate clinical question: What is the value ofascitic fluid ADA for the diagnosis of peritoneal tuberculosis?

  • 7/29/2019 Ppt Case Rscm1

    10/21

    Searching the evidence

  • 7/29/2019 Ppt Case Rscm1

    11/21

    Result

    5 articles included:

    Riquelme et al, 2006

    Saleh et al, 2012

    Sharma et al, 2006

    Burgess et al, 2001

    Sathar et al, 1995

    Meta-analysis was appraised using Q-FAST tool

    Other 4 prospective studies was appraised for its

    VIA

  • 7/29/2019 Ppt Case Rscm1

    12/21

    Critical appraisalItem Summary of Riquelme et al, 2006Q-question The study was based on clear clinical question and it is similar to oursF-finding Inclusion criteria and search methods are stated in the methods section,

    inclusion criteria were based on the clinical question.A primary search of the literature was conducted including MEDLINE(PubMed) and hand searching, no limits regarding language4 prospective studies were included in the meta-analysis

    A-appraise Individual prospective studies were critically appraised by twoindependent reviewers, agreement between reviewers for article selectionwas measured as kappa coefficient of only 0.43 (moderate), probabledue to small number of selected articles.

    S-synthesis The paper includes a clear summary table of the included studies andheterogeneity analysis was done. Four individual studies were homogen.

    T-transferability The result of study was applicable on our patient because similarity in thedomain, determinant and outcome.

  • 7/29/2019 Ppt Case Rscm1

    13/21

    Validity

    Study Independent andblind comparison Appropriatespectrum of patient Reference standardascertained regardless

    of the index test result

    Saleh et al, 2012 Yes Yes YesSharma et al, 2006 Yes Yes Yes

    Burgess et al, 2001 Yes Yes Yes

    Sathar et al, 1995 Yes Yes Yes

  • 7/29/2019 Ppt Case Rscm1

    14/21

    Importance

    Study N Best ROC curvecut-off ADAvalue (IU/L)

    AUC Sn(%) Sp(%) LRs(+) PPV(%) NPV(%)

    Riquelme, et al 264 39 0.99 100 97 26.8 N/A N/ASaleh et al, 2012 41 35 0.99 100 92,6 N/A 87,5 100Sharma et al, 2006 119 37 0.98 97 94 N/A N/A N/A

    Burgess et al, 2001 178 30 0.92 94 92 N/A 57 99

    Sathar et al, 1995 92 30 0.95 93 96 N/A 93 96

  • 7/29/2019 Ppt Case Rscm1

    15/21

    Applicability

    Study The test is available,affordable, accurate

    and precise in oursetting

    Ability to generate anestimate of patients

    pre-test probabilityThe resulting post-testprobabilities will affectmanagement and help

    patient

    Saleh et al, 2012 Yes Yes YesSharma et al, 2006 Yes Yes Yes

    Burgess et al, 2001 Yes Yes Yes

    Sathar et al, 1995

    Yes

    Yes

    Yes

  • 7/29/2019 Ppt Case Rscm1

    16/21

    Discussion

    All studies agreed that ADA is increased in tuberculousascitic fluid because of the stimulation of T cells by themycobacterial antigens, sensitivity and specificity levelsover 90% have been reported in all studies.

    We admit that we might have missed relevant articles, we

    excluded all hits that were not in English publication andnot available with full text on the Internet, which can be anegative contributor.

    When applying the results of best available evidence toour patient, we have to consider that the meta-analysisincluded population from Chile and India, where a higherfrequency of TB was observed and was similar to ours,where TB is endemic.

    Therefore, we can extrapolate the result on our patient.

  • 7/29/2019 Ppt Case Rscm1

    17/21

    Discussion

    Our patient with clinicalfeatures suggestive of PTB,has a 50% pretest probabilityof having PTB.

    If the ascites fluid study shows

    an ADA level of 107 IU/L (>39,LR+ 26.8) she therefore has a96 % posttest probability ofhaving PTB.

    The clinical relevance of thistest is evident ever because it

    may avoid the need toconfirm the diagnosis withinvasive techniques such aslaparoscopy.

  • 7/29/2019 Ppt Case Rscm1

    18/21

    Discussion

    Then, we decide to treat our patient with a 4-drugcombination of anti-tuberculosis.

    However, the CDC in United State insists the need

    of a sensitivity in vitro test in every patient with PTBto determine the epidemiology of MTB.

    It is known that even using the most advancedtechniques to isolate the Mycobacterium, the rate

    of positive test is still low and we consider ADAactivity is a practical and useful approach to maketherapeutic decision in patients suspected PTB.

  • 7/29/2019 Ppt Case Rscm1

    19/21

    Discussion

    After 8 weeks of anti-tuberculosis treatment, onthe follow up of our patient, she recovered fromconstitutional symptoms and her abdominalcircumference was reduced from 112 cm to 102

    cm.

    She was planned to have a 9-month course ofanti-tuberculosis drugs that consist of 2 months ofinitial phase and 7 months of continuation phase.

  • 7/29/2019 Ppt Case Rscm1

    20/21

    Conclusion

    Measurement of an ascitic ADA activity yields a high

    rate of diagnostic accuracy for PTB and it is an easy

    available test.

    It may help clinicians to decide whether or not to treat

    patients with ascites who clinically suspicious for PTB.

    To start empirical treatment on a patient with high ADA

    value in ascitic fluid seems to be a good approach

    while waiting for the results of cultures or biopsies.

    We do recommend the utilization of this test in the

    diagnostic work-up of patients with suspected PTB.

  • 7/29/2019 Ppt Case Rscm1

    21/21

    Thank you